| Literature DB >> 18553955 |
Lisa D Julian1, Zhulun Wang, Tracy Bostick, Seb Caille, Rebekah Choi, Michael DeGraffenreid, Yongmei Di, Xiao He, Randall W Hungate, Juan C Jaen, Jinsong Liu, Mario Monshouwer, Dustin McMinn, Yosup Rew, Athena Sudom, Daqing Sun, Hua Tu, Stefania Ursu, Nigel Walker, Xuelei Yan, Qiuping Ye, Jay P Powers.
Abstract
We report the discovery of potent benzamide inhibitors of 11beta-hydroxysteroid dehydrogenase (11beta-HSD1). The optimization and correlation of in vitro and in vivo metabolic stability will be described. Through modifications to our initial lead 2, we discovered pyridyl compound 13. This compound has a favorable pharmacokinetic profile across three species and showed a dose-dependent decrease in adipose 11beta-HSD1 activity in a monkey ex vivo pharmacodynamic model.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18553955 DOI: 10.1021/jm800310g
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446